ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer

ClinicalTrials.gov ID: NCT02163694

Public ClinicalTrials.gov record NCT02163694. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the PARP Inhibitor Veliparib (ABT-888) in HER2-Negative Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer

Study identification

NCT ID
NCT02163694
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
513 participants

Conditions and interventions

Interventions

  • Carboplatin Drug
  • Paclitaxel Drug
  • Veliparib Drug
  • Veliparib Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 7, 2014
Primary completion
Apr 4, 2019
Completion
Jan 24, 2024
Last update posted
Feb 18, 2025

2014 – 2024

United States locations

U.S. sites
56
U.S. states
25
U.S. cities
51
Facility City State ZIP Site status
Banner MD Anderson Cancer Ctr /ID# 125011 Gilbert Arizona 85234
University of Arkansas for Medical Sciences /ID# 124992 Little Rock Arkansas 72205
City of Hope /ID# 127117 Duarte California 91010
California Cancer Associates for Research & Excellence (cCARE) /ID# 136078 Fresno California 93720
Moores Cancer Center at UC San Diego /ID# 124991 La Jolla California 92093
Hematology and Oncology Assoc /ID# 130058 Newport Beach California 92663
Cancer Research Collaboration /ID# 128860 Santa Ana California 92705
Icri /Id# 128520 Whittier California 90603
Univ of Colorado Cancer Center /ID# 124983 Aurora Colorado 80045
Saint Joseph Hospital /ID# 131768 Denver Colorado 80218
Norwalk Hospital /ID# 133509 Norwalk Connecticut 06856
Lynn Cancer Institute, Boca /ID# 125013 Boca Raton Florida 33486
Holy Cross Hospital /ID# 125012 Fort Lauderdale Florida 33308
Sacred Heart Hospital /ID# 128279 Pensacola Florida 32504
Moffitt Cancer Center /ID# 124990 Tampa Florida 33612-9416
Florida Cancer Specialists - East /ID# 125007 West Palm Beach Florida 33401
Emory Midtown Infectious Disease Clinic /ID# 133192 Atlanta Georgia 30322
The Cancer Ctr at DeKalb Med C /ID# 125024 Decatur Georgia 30033
University of Illinois - Chicago /ID# 127576 Chicago Illinois 60607
NorthShore University HealthSystem /ID# 124996 Evanston Illinois 60201
Midwestern Regional CTC /ID# 124986 Zion Illinois 60099
McFarland Clinic, PC /ID# 129904 Ames Iowa 50010
Johns Hopkins University /ID# 125015 Baltimore Maryland 21287
Baystate Medical Center /ID# 139461 Springfield Massachusetts 01199
UMass Chan Medical School /ID# 129067 Worcester Massachusetts 01655
Henry Ford Health System /ID# 134497 Detroit Michigan 48202
Spectrum Health Medical Group /ID# 133568 Grand Rapids Michigan 49503
Spectrum Health Medical Group /ID# 148471 Grand Rapids Michigan 49503
William Beaumont Hospital /ID# 125019 Royal Oak Michigan 48073-6710
Univ of Mississippi Med Ctr,US /ID# 131352 Jackson Mississippi 39216-4643
St. Lukes Cancer Institute /ID# 125023 Kansas City Missouri 64111-5905
Washington University-School of Medicine /ID# 127575 St Louis Missouri 63110
Nebraska Hematology Oncology /ID# 132711 Lincoln Nebraska 68506
Rutgers Cancer Institute of New Jersey /ID# 125017 New Brunswick New Jersey 08901
University of New Mexico /ID# 125349 Albuquerque New Mexico 87102-4517
Beth Israel Medical Center /ID# 125001 New York New York 10003
Mount Sinai St. Luke's /ID# 125003 New York New York 10025
Mission Cancer Center /ID# 134248 Asheville North Carolina 28801
Duke Cancer Center /ID# 124999 Durham North Carolina 27710-3000
The Ohio State University /ID# 125022 Columbus Ohio 43210
University of Toledo /ID# 134849 Toledo Ohio 43614
Oregon Health and Science University /ID# 134229 Portland Oregon 97239
Lehigh Valley Health Network /ID# 130059 Allentown Pennsylvania 18103
Lehigh Valley Hosp/Muhlenberg /ID# 130277 Bethlehem Pennsylvania 18017
Penn State University and Milton S. Hershey Medical Center /ID# 124997 Hershey Pennsylvania 17033
Allegheny General Hospital /ID# 135094 Pittsburgh Pennsylvania 15212
University of Pittsburgh MC /ID# 125005 Pittsburgh Pennsylvania 15260
Texas Health Physicians Group /ID# 137740 Arlington Texas 76012
University of Texas Southwestern Medical Center /ID# 124989 Dallas Texas 75390-7208
University of Texas MD Anderson Cancer Center /ID# 125353 Houston Texas 77030
University of Vermont Medical Center /ID# 125350 Burlington Vermont 05401-1473
Swedish Cancer Institute - Issaquah /ID# 131534 Issaquah Washington 98029-6201
Swedish Cancer Institute - Edmonds /ID# 131549 Seattle Washington 98104
Swedish Medical Center /ID# 125021 Seattle Washington 98104
Swedish Cancer Insititute - Ballard /ID# 131548 Seattle Washington 98107-3932
Northwest Medical Specialties - Tacoma /ID# 125344 Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 163 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02163694, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 18, 2025 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02163694 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →